Home Search

Aimmune Begins Patient Enrollment for Phase III Clinical Trial of Peanut Therapy

Dave Bloom - 2017/05/17 0

First of 440 patients enrolled in study of AR101.

Breakthrough Food Allergy Therapies and the Big Business Behind Them

Dave Bloom - 2015/10/28 1

What it means to be a breakthrough therapy, who is developing them, how they work, and the (big) business drivers behind them.

1...3 45Page 5 of 5

Put Your School on the Map

Dave Bloom - 2024/07/31 0

Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

ar101 - search results

Aimmune Begins Patient Enrollment for Phase III Clinical Trial of Peanut Therapy

Breakthrough Food Allergy Therapies and the Big Business Behind Them

Your School On Our Map

Put Your School on the Map